Vir Biotechnology director granted RSUs and options
Vir Biotechnology, Inc. director Jeffrey S. Hatfield reported receiving new equity compensation.
Rhea-AI Filing Summary
Vir Biotechnology, Inc. director Jeffrey S. Hatfield reported receiving new equity compensation. He acquired 8,000 restricted stock units (RSUs) under the company’s Equity Incentive Plan, which will vest in full on May 27, 2027. He also received a stock option for 16,000 shares of common stock at an exercise price of $9.10 per share, vesting and becoming exercisable in full on May 27, 2027 and expiring on May 26, 2036. Following the RSU grant, he holds 39,806 shares of common stock directly. These awards are compensation-related grants rather than open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 24,000 shares
Grant/Award
2 txns
Insider
Hatfield Jeffrey S.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 16,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 8,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 16,000 contracts (Direct);
Common Stock — 39,806 shares (Direct)
Footnotes (3)
- F1. Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F2. The RSUs will vest in full on May 27, 2027.
- F3. The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.
Key Figures
RSU grant: 8,000 RSUs
Stock option grant: 16,000 options
Option exercise price: $9.10 per share
+4 more
7 metrics
RSU grant
8,000 RSUs
Granted to director on May 27, 2026; vest in full May 27, 2027
Stock option grant
16,000 options
Right to buy common stock; granted May 27, 2026
Option exercise price
$9.10 per share
Exercise price for 16,000-share stock option
Shares after RSU grant
39,806 shares
Common stock held directly following the transaction
RSU vesting date
May 27, 2027
Date when 8,000 RSUs vest in full
Option vesting date
May 27, 2027
Date when 16,000 options become fully exercisable
Option expiration
May 26, 2036
Expiration date of the 16,000-share stock option
Key Terms
restricted stock units (RSUs), Equity Incentive Plan, Stock Option (Right to Buy), vesting, +1 more
5 terms
restricted stock units (RSUs) financial
"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Equity Incentive Plan financial
"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying security title Common Stock."
vesting financial
"The RSUs will vest in full on May 27, 2027."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price of 9.1000 per share for the stock option."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Vir Biotechnology (VIR) director Jeffrey Hatfield receive?
Jeffrey Hatfield received 8,000 restricted stock units and a stock option for 16,000 shares of Vir Biotechnology common stock. Both awards were granted as compensation under the company’s Equity Incentive Plan, rather than through open-market trading in the company’s shares.
What is the vesting schedule for Jeffrey Hatfield’s new Vir (VIR) RSUs and options?
Both the 8,000 restricted stock units and the stock option covering 16,000 shares will vest in full on May 27, 2027. On that date, the RSUs convert to shares and the option becomes fully exercisable, assuming continued service through vesting.
What is the exercise price and expiration date of Jeffrey Hatfield’s Vir (VIR) stock option?
The stock option granted to Jeffrey Hatfield covers 16,000 shares at an exercise price of $9.10 per share. The option becomes fully exercisable on May 27, 2027 and will expire on May 26, 2036 if not exercised before that date.
Are Jeffrey Hatfield’s Vir (VIR) equity grants open-market purchases or sales?
The reported transactions are not open-market trades. They are compensation-related grants: 8,000 restricted stock units and a stock option for 16,000 shares, both awarded at no cash cost to Hatfield under Vir Biotechnology’s Equity Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
